The advent of oncolytic virotherapy in oncology: The Rigvir® storyPēteris Alberts, Dite Venskus, Andra Tilgase et al.|European Journal of Pharmacology|2018Cited by 179
Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective studySimona Doniņa, A. Muceniece, Ieva Strēle et al.|Melanoma Research|2015Cited by 125
Long‐term treatment with the oncolytic ECHO‐7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient‐three case reportsPēteris Alberts, Dite Venskus, Evija Olmane et al.|Apmis|2016Cited by 54